- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05623826
Feasibility and Efficacy of a Digital Training Intervention to Increase Reward Sensitivity- Imager (IMAGER)
Feasibility and Efficacy of Imager, a Digital Training Intervention to Increase Reward Sensitivity: A Randomised Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Aim of the current project is to develop and test Ecological Momentary Intervention (EMI) - Imager, to promote and improve stress resilience, specifically to increase reward sensitivity. EMIs are mostly smartphone-based applications that deliver interventions to people as they go about in their daily lives. The EMI developed and tested here is based on theoretical and empirical findings and consists of several items and a repeated training using various individual scenarios from participants' life that will be presented to participants via an app on their smartphones.
This study tests the feasibility and effects of the EMI on a change in (i) reward sensitivity, (ii) mental imagery, and (iii) indices of perceived stress. One hundred twenty healthy student participants, aged 18-29 will be included in the study. Participants will be screened first and included if they score 5 points or more on the Reward Sensitivity Subscale of Behavioral Avoidance/Inhibition (BIS/BAS) scales. This is necessary in order to avoid a ceiling effect. Then, participants will be randomly assigned to an experimental (reward sensitivity EMI) or two of the control conditions (control EMA or waitlist). The reward sensitivity EMI group will be taught about experiencing rewards in daily life and will be asked to apply the specific techniques to personal situations repeatedly. The control EMA group will use the same app consisting of Ecological Momentary Assessment only, and the waitlist group will not receive any mobile app.
The training will last seven consecutive days and the app will send (i) 10 prompts per day to ask about the current mood of the user in control EMA and experimental groups and (ii) three prompts per day resulting in a total of 21 reward training sessions only in the experimental group. Participants will be able to use a special button triggering the intervention or EMA by themselves too. After one week, participants will return to the lab, fill in questionnaires and participate in behavioral tasks.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Zurich
-
Zürich, Zurich, Switzerland, 8032
- Psychiatric University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- being a student
- having sufficient knowledge of the German language
- being a smartphone user
- score of 5 points or more in Reward Sensitivity Subscale of Behavioral Avoidance/Inhibition (BIS/BAS) scales
Exclusion Criteria:
- having a mental illness or attending the psychotherapy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Experimental
Experimental (receiving EMA and Imager EMI)
|
The EMI developed and tested here is based on theoretical and empirical findings and consists of several items and a repeated training using various individual scenarios from participants' life that will be presented to participants via an app on their smartphones.
Other Names:
|
|
No Intervention: Control
Control (receiving EMA only)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Behavioural avoidance/inhibition (BIS/BAS) scales
Time Frame: one week: Pre- to post-intervention/control
|
Self-reported reward sensitivity, scale range [0-15], higher score = worse outcome
|
one week: Pre- to post-intervention/control
|
|
The Sensitivity to Punishment and Sensitivity to Reward Questionnaire (SPSRQ)
Time Frame: one week: Pre- to post-intervention/control
|
Self-reported reward sensitivity, scale range [0-24], higher score = better outcome
|
one week: Pre- to post-intervention/control
|
|
Perceived Stress Scale (PSS)
Time Frame: one week: Pre- to post-intervention/control
|
Self-reported level of stress, scale range [0-40], higher score = worse outcome
|
one week: Pre- to post-intervention/control
|
|
Beck Depression Inventory II (BDI-II)
Time Frame: one week: Pre- to post-intervention/control
|
Self-reported depressive symptoms, scale range [0-63], higher score = worse outcome
|
one week: Pre- to post-intervention/control
|
|
State-Trait Anxiety Inventory (STAI)
Time Frame: one week: Pre- to post-intervention/control
|
Self-reported anxiety symptoms, scale range [20-80], higher score = worse outcome
|
one week: Pre- to post-intervention/control
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Birgit Kleim, PhD, University of Zurich
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- UZH_Imager
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- Clinical Study Report (CSR)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.